📋 Tender Overview
Contract awarded for 2026/0448 - centralized aggregation for additional medications for the year 2026 lot-0003, title: bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc p/a sol p/a perfusão; frs] + bevacizumab [25 mg/ml; 400 mg/ 16 ml; conc p/a sol p/a perfusão; frs], description: bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc p/a sol p/a perfusão; frs] + bevacizumab [25 mg/ml; 400 mg/ 16 ml; conc p/a sol p/a perfusão; frs] estimated value excluding vat: 22870.00 eur.2026/0448 - centralized aggregation for additional medications for the year 2026
